about
NSAID therapy effects on healing of bone, tendon, and the enthesisThe effects of ketorolac injected via patient controlled analgesia postoperatively on spinal fusionA comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing.Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone HealingMatrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering.Intravenous ibuprofen: the first injectable product for the treatment of pain and fever.Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.Emerging ideas: can erythromycin reduce the risk of aseptic loosening?EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repairCOX-2 selective inhibitors and bone.Salicylic Acid-Based Polymers for Guided Bone Regeneration Using Bone Morphogenetic Protein-2Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats.Prevention of heterotopic ossification: an experimental study using a plasma expander in a murine model.Cyclooxygenase-2 inhibitor reduces simvastatin-induced bone morphogenetic protein-2 and bone formation in vivo.Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation.Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.Alteration of femoral bone morphology and density in COX-2-/- mice.Use of imatinib in the prevention of heterotopic ossification.Parecoxib and indomethacin delay early fracture healing: a study in rats.Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4.Parecoxib has non-significant long-term effects on bone healing in rats when administered for a short period after fracture.Stress fractures-a prospective study amongst recruits.Pathophysiology of cyclooxygenase inhibition in animal models.Qualifying stem cell sources: how to overcome potential pitfalls in regenerative medicine?Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism.Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.Prostaglandin D2 pathway and peroxisome proliferator-activated receptor gamma-1 expression are induced by mechanical loading in an osteoblastic cell line.The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study.Short-term treatment with COX-2 inhibitors does not impair fracture healing.Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing.The regeneration of the tail fin actinotrichia of carp (Cyprinus carpio, Linnaeus, 1758) under the action of naproxen.Influence of non-steroidal anti-inflammatory drugs (NSAIDs) on osseointegration of dental implants in rabbit calvaria.Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway.Selective COX-2 inhibitor reduces bone healing in bone defects.Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.Effects of NSAIDs and hydroxyapatite coating on osseointegration.Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis.The effect of non-steroidal anti-inflammatory drugs on the osteogenic activity in osseointegration: a systematic review
P2860
Q27007096-0E52B1AB-F97D-4E9B-8A03-7414D9332738Q28174517-9FC27FAF-5025-436E-9453-83AFC8D05937Q33660915-319FC0AC-ECAC-462B-935C-C2435D1600F9Q33664353-125AAA51-18FF-4EF5-91B3-A584AE26665EQ33668926-6C51062F-2988-40F2-A1B1-F86829D54E92Q34418336-2770AF1B-DBF6-4C6A-A9FA-843ACF68DB00Q34459614-E5908B91-5F28-4F30-A266-5CB64F0BC56EQ35078775-C13DB99D-5B33-47E3-BD74-876D245FB213Q35229997-13E5B197-599C-47C4-94DC-FEBD2F07A8A8Q35581260-ECC571FF-8F6B-4D68-B807-BB671A756CABQ35865353-505650CE-403B-40B4-93A7-EA0028129307Q35935036-3058E174-225D-4E60-889D-B2F53AC2C910Q36008509-4B999623-B3ED-45C8-871F-5C4F0541CE14Q36054538-F1FE942A-0C32-4E16-858A-8467DD806C76Q36291161-B91846C1-34E8-444C-8089-5D76B3EDAEA8Q36987298-7356E867-3DE2-4194-A8C2-E2E2394DCB47Q37110168-003C60CC-710D-48DE-961E-CE5A91B39818Q37132961-04206C27-ECB5-4C1D-9170-73FD53EBE36FQ37251966-CB79DE73-70DA-4179-870B-7434482A5684Q37278490-D19FFCE2-0DFB-4DA0-97B6-4B62469DF1FFQ37313416-D6F20A41-9648-48D2-B68A-1584FDFB223FQ37391541-83ACC3B4-04D2-4DF2-B309-F8340D3446B0Q37398476-B69C16C1-C756-4EA8-A1D5-59E2BD331770Q38219585-6C7F5A9A-9D99-4367-A18F-F765B1D6EFF8Q39475508-21B4DD3A-95AD-4167-B2F3-7439782BAE3BQ39673628-D5D8367A-4C3E-4826-9403-C8985210351EQ40087307-1056356D-316C-47FD-8FFC-FDBD7659A6C8Q40311942-16935F48-238D-401C-A343-9BD1CEE7A086Q41579402-5F894770-5001-419E-AA30-C39EE50709D2Q42875390-7C5427E0-08C4-4BAE-9424-9ACEBBACA166Q42917193-9A8C80FF-CC1A-4009-B279-92183AB6BCC5Q43228398-E2AAF89A-D90B-4132-9D04-9EB8A9BF71A9Q43438131-1A850B84-0339-4224-8F04-4D1699F86149Q46183672-56F0E56A-E580-4722-8FF2-3FA803578A77Q46954749-156871CA-BFAF-431D-B498-208C25782FE1Q47137932-CE6F7ACA-E7CD-40EB-BC00-D6BE68818318Q51024092-1844B81C-9EC6-4356-9E56-5CD79A1E9FC3Q55055573-7128CF8B-3726-4C85-92D6-DC0BCD567277Q57289087-B9174EAF-4690-4D56-965F-ED889022F714
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
COX-2 selective NSAID decreases bone ingrowth in vivo.
@en
COX-2 selective NSAID decreases bone ingrowth in vivo.
@nl
type
label
COX-2 selective NSAID decreases bone ingrowth in vivo.
@en
COX-2 selective NSAID decreases bone ingrowth in vivo.
@nl
prefLabel
COX-2 selective NSAID decreases bone ingrowth in vivo.
@en
COX-2 selective NSAID decreases bone ingrowth in vivo.
@nl
P2093
P2860
P1476
COX-2 selective NSAID decreases bone ingrowth in vivo.
@en
P2093
Don Regula
Ippe Matsuura
Mark Genovese
Michael Trindade
R Lane Smith
Stuart Goodman
Takashi Ikenoue
P2860
P304
P356
10.1016/S0736-0266(02)00079-7
P577
2002-11-01T00:00:00Z